Discussing the lack of diversity in the psychedelics space with Jennifer Montjoy.
Similar Posts
Fireside Project
Fireside Project is excited to launch on April 14th as a 24/7 support hotline
Interview With Kelsey Ramsden, President and CEO of Mind Cure
Kelsey Ramsden, the President, and CEO of Mind Cure Health Inc. sheds light on the advancements Mind Cure is currently making.
Investing in Psychedelic Stocks 101 [ Interview With The Medicine Of Being Human]
Hello Psychedelic Investors! As I mentioned in the previous episode of the Psychedelic Investor, last week I had my first ever interview with the wonderful Sena who is interested in creating a resource for those new to investing in psychedelic stocks and investing in stocks in general.
For those interested in the basics on psychedelic investing, you can watch the entire video on:
The Medicine of Being Human :https://www.youtube.com/watch?v=p3d_t4GYG14&t=599s&ab_channel=TheMedicineofBeingHuman
#PsychedelicStocks #MindMed #ThePsychedelicInvestor
I hope you guys found some value in this and I’ll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
Defiance Just Launched the World’s Second Psychedelics-Focused ETF
Defiance has launched the world’s second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.
Interview With Dr. Joseph Tucker
MagicMed Industries’ CEO, Dr. Joseph Tucker, talks about their psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.